Xiaohong Yuan
Capital Medical University
7 Papers
Xiaohong Yuan is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
Xiaoqiang Wang,Dongfang Chen,Yumiao Shi,Jiamei Luo,Yiqi Zhang,Xiaohong Yuan,Chao-Nan Zhang,Weifeng Yu,Jie Tian +8 more
TL;DR: In this paper , the effects of Cu and cuproptosis-related genes (CRGs) in patients with HCC were investigated in the TCGA-LIHC (The Cancer Genome Atlas-Liver cancer, n = 347) and ICGC-LIRI-JP (International Cancer Gome Consortium-liver Cancer-Riken-Japan), datasets.
Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma.
TL;DR: It was found that patients in the stroma-rich group had a worse long-term prognosis and a risk model that combined the TSR and TB proved to be valuable for predicting OTSCC patients outcome.
8
PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma
Che Qin,Siyuan Liu,Shiqi Zhou,Qibo Wang,Xianghou Xia,Jiejie Hu,Xiaohong Yuan,Zongping Wang,Yang Yu,de Jongh Ma +9 more
TL;DR: In this article , the role of PIK3C2A in cancer prognosis and progression remains unknown, however, the expression pattern and prognostic significance of pIK3c2a in human malignancies were investigated using multiple datasets and scRNA-seq data.
Development and validation of a nomogram for the prediction of lymph node metastasis within 2‐year postoperatively in cT1‐T2N0 oral squamous cell carcinoma
Aoming Cheng,Zhen Wang,Xiaohong Yuan,Huan Liu,Wei Cao,Wei Wei,Shimin Chang,Zhengxue Han,Chuan-bin Guo,Zhien Feng +9 more
TL;DR: The nomogram model has an advantage over the 8th AJCC TNM stage in predicting the individual 2-year LNM probability for early OSCC, and patients with low-risk nomogram score may receive neck observation; those with high-risk score should receive END.
3
A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma
TL;DR: A novel immune-associated gene signature was identified for predicting the prognosis of oral squamous cell carcinoma patients and these risk genes show great potential as targets for OSCC treatment.
1